Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Tegileridine in Renal Insufficiency
NCT07189962Phase 1Completed
- Sponsor
- Hengrui
- Start
- Sep 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of tegileridine in postoperative pain (2 arms), sponsored by Hengrui. Primary endpoints: Maximum observed concentration, Area under the serum concentration time curve and 3 more. Started Sep 2022; status: completed.
02
Drugs
tegileridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07189962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07189962.